DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

R. L. Hansen; T. S. Jørgensen; A. Egeberg; N. Lippert Rosenoe; M. Skougaard; Z. R. Stisen; L. Dreyer; L. E. Kristensen

doi:10.1136/annrheumdis-2022-eular.921

DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

R. L. Hansen, T. S. Jørgensen, A. Egeberg, N. Lippert Rosenoe, M. Skougaard, Z. R. Stisen, L. Dreyer, L. E. Kristensen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	POS1018
Journal	Annals of the Rheumatic Diseases
Volume	81
Issue number	Suppl. 1
Pages (from-to)	819-820
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2022-eular.921
Publication status	Published - Jun 2022
Event	Annual European Congress of Rheumatology, EULAR 2022 - Copenhagen, Denmark Duration: 1 Jun 2022 → 4 Jun 2022 https://www.congress.eular.org/

Conference

Conference	Annual European Congress of Rheumatology, EULAR 2022
Country/Territory	Denmark
City	Copenhagen
Period	01/06/2022 → 04/06/2022
Internet address	https://www.congress.eular.org/

Bibliographical note

Abstract No. POS1018

Access to Document

10.1136/annrheumdis-2022-eular.921

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Hansen, R. L., Jørgensen, T. S., Egeberg, A., Rosenoe, N. L., Skougaard, M., Stisen, Z. R., Dreyer, L., & Kristensen, L. E. (2022). DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY. Annals of the Rheumatic Diseases, 81(Suppl. 1), 819-820. Article POS1018. https://doi.org/10.1136/annrheumdis-2022-eular.921

@article{b3b3d192e9784d1b8034f9594b57140a,

title = "DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY",

author = "Hansen, {R. L.} and J{\o}rgensen, {T. S.} and A. Egeberg and Rosenoe, {N. Lippert} and M. Skougaard and Stisen, {Z. R.} and L. Dreyer and Kristensen, {L. E.}",

note = "Abstract No. POS1018; Annual European Congress of Rheumatology, EULAR 2022 ; Conference date: 01-06-2022 Through 04-06-2022",

year = "2022",

month = jun,

doi = "10.1136/annrheumdis-2022-eular.921",

language = "English",

volume = "81",

pages = "819--820",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

url = "https://www.congress.eular.org/",

}

Hansen, RL, Jørgensen, TS, Egeberg, A, Rosenoe, NL, Skougaard, M, Stisen, ZR, Dreyer, L & Kristensen, LE 2022, 'DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, POS1018, pp. 819-820. https://doi.org/10.1136/annrheumdis-2022-eular.921

DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY. / Hansen, R. L.; Jørgensen, T. S.; Egeberg, A. et al.
In: Annals of the Rheumatic Diseases, Vol. 81, No. Suppl. 1, POS1018, 06.2022, p. 819-820.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - DRUG SURVIVAL AND TREATMENT RESPONSE RATES IN PSORIATIC ARTHRITIS PATIENTS SWITCHING TO FIRST- OR SECOND-LINE IL-17 INHIBITOR TREATMENT: A DANISH POPULATION-BASED COHORT STUDY

AU - Hansen, R. L.

AU - Jørgensen, T. S.

AU - Egeberg, A.

AU - Rosenoe, N. Lippert

AU - Skougaard, M.

AU - Stisen, Z. R.

AU - Dreyer, L.

AU - Kristensen, L. E.

N1 - Abstract No. POS1018

PY - 2022/6

Y1 - 2022/6

U2 - 10.1136/annrheumdis-2022-eular.921

DO - 10.1136/annrheumdis-2022-eular.921

M3 - Conference abstract in journal

SN - 0003-4967

VL - 81

SP - 819

EP - 820

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - POS1018

T2 - Annual European Congress of Rheumatology, EULAR 2022

Y2 - 1 June 2022 through 4 June 2022

ER -